ARIAD Pharma (ARIA) Misses Q1 EPS by 2c
Tweet
Share
E-mailGet Alerts ARIA Hot Sheet
Price: $24.82 -0.48%
Financial Fact:
Total operating expenses: 71.01M
Today's EPS Names:
EDXC, BICX, FBPI, More
Financial Fact:
Total operating expenses: 71.01M
Today's EPS Names:
EDXC, BICX, FBPI, More
Join SI Premium – FREE
ARIAD Pharma (NASDAQ: ARIA) reported Q1 EPS of ($0.28), $0.02 worse than the analyst estimate of ($0.26). Revenue for the quarter came in at $23.9 million versus the consensus estimate of $27.26 million.
For earnings history and earnings-related data on ARIAD Pharma (ARIA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Etsy upgraded to buy at BofA on durable growth, buyback potential
- Twin Disc (TWIN) Tops Q4 EPS by 16c
- Firm Capital Apartment REIT posts Q2 loss, plans name change
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
